跳至内容
当前位置: 首页 产品中心 分析试剂 生物试剂 p27 Kip1 (C Terminus) blocking peptide|GTX89293-PEP|100μg
p27 Kip1 (C Terminus) blocking peptide|GTX89293-PEP|100μg
图片仅供参考,具体产品以实物为准!

p27 Kip1 (C Terminus) blocking peptide|GTX89293-PEP|100μg

GTX89293-PEP
p27 Kip1 (C Terminus) blocking peptide
¥ 3200.0
¥ 3200.0
100μg
萘析精选
见详情
− +
0
p27 Kip1 (C Terminus) blocking peptide介绍:

产品名称:
p27 Kip1 (C Terminus) blocking peptide
别名:
Cyclin Dependent Kinase Inhibitor 1B , Cdkn4 , Kip1 , Men1B , Men4 , P27Kip1 , Cdkn1B
靶标/特异性:
The peptide was used in the production of GTX89293.
克隆号:
产品浓度:
保存温度:
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
运输温度:
4°C
产品形式:
Lyophilized powder
存储溶液:
Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O, no preservatives.
生产商:
GeneTex
功能与背景:
This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4). [provided by RefSeq, Apr 2014]

本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。

暂无标准解读内容
暂无常见问题内容